Posts filed under: News

MELBOURNE, Australia and KYOTO Japan, Jan. 15, 2018 – Telix Pharmaceuticals Limited has today announced the establishment Telix Pharmaceuticals (Japan) Ltd and appointment of the first two members of the...
Continue Reading →
MELBOURNE, Australia and NEW YORK, Dec. 14, 2017 – Telix Pharmaceuticals Limited has today announced a collaboration with Memorial Sloan Kettering Cancer Center. To read the full media release click...
Continue Reading →
MELBOURNE, Australia and TOKYO, Dec. 13, 2017 – Telix Pharmaceuticals Limited  has today announced a manufacturing partnership with JFE Engineering Corporation.  To read the full media release click here....
Continue Reading →
MELBOURNE, Australia and INDIANAPOLIS, Dec. 04, 2017 – Telix Pharmaceuticals Limited, has today announced the appointment of Dr. Bernard Lambert as President and Chief Operating Officer (COO) of Telix’s US...
Continue Reading →
Melbourne, Australia, November 15, 2017 – Telix Pharmaceuticals Limited has today listed on the Australian Securities Exchange (ASX) after raising $50 million in a fully underwritten Initial Public Offering (IPO). The...
Continue Reading →
Melbourne, Australia, November 09, 2017 – Telix Pharmaceuticals Limited has successfully raised $50 million following the close of its fully underwritten Initial Public Offering (IPO). The IPO was strongly supported by...
Continue Reading →
Telix Pharmaceuticals Limited IPO briefing event: Sydney: Tuesday 31st October at The Grace Hotel To find out more and RSVP, click here. Melbourne: Wednesday 1st November at The Westin To find out more and RSVP,...
Continue Reading →
Melbourne, Australia, and LIÈGE, Belgium, Oct. 24, 2017 – Telix Pharmaceuticals (Telix) is pleased to announce that it has entered into a development and commercialisation partnership with Advanced Nuclear Medicine Ingredients SA...
Continue Reading →
Melbourne, Australia, October 23, 2017 – Telix Pharmaceuticals Limited is pleased to announce the opening of its Initial Public Offering to raise A$50 million. Click here to view the full release....
Continue Reading →
Melbourne, Australia, October 18, 2017 – Telix Pharmaceuticals Limited (Telix) is pleased to announce that it has entered into a technology licensing agreement and a research collaboration agreement with the University of...
Continue Reading →